Study Details
Full Title
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
Principal Investigator
Angeles
Secord
Protocol Number
PRO00110517
NCT ID
NCT05128825
Phase
II
Enrollment Status
Open to Enrollment